Skinspecific unsaturated fatty acids boost the Staphylococcus aureus innate immune response

Infection and Immunity

Volumn 84, Issue 1, 2015, Pages 205-215

  Nguyen, Minh Thu ^a,b   Hanzelmann, Dennis ^a   Härtner, Thomas ^a   Peschel, Andreas ^a   Götz, Friedrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HANOI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; LINOLEIC ACID; LIPOPROTEIN; PHOSPHOLIPID; TOLL LIKE RECEPTOR 2; UNSATURATED FATTY ACID; PHOSPHATIDYLGLYCEROL GLYCERYL TRANSFERASE; TLR2 PROTEIN, HUMAN; TRANSFERASE;

ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; CELL LYSATE; FATTY ACID SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INNATE IMMUNITY; LIPID ANALYSIS; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SKIN; STAPHYLOCOCCUS AUREUS; CELL MEMBRANE; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MONONUCLEAR CELL; STAPHYLOCOCCUS INFECTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MEMBRANE; FATTY ACIDS, UNSATURATED; HUMANS; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 2; TRANSFERASES;

EID: 84957644538     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00822-15     Document Type: Article

References (62)

1. Swamy M, Jamora C, Havran W, Hayday A. 2010. Epithelial decision makers: in search of the 'epimmunome.' Nat Immunol 11:656-665. http://dx.doi.org/10.1038/ni.1905.
2. Volz T, Kaesler S, Biedermann T. 2012. Innate immune sensing 2.0-from linear activation pathways to fine tuned and regulated innate immune networks. Exp Dermatol 21:61-69. http://dx.doi.org/10.1111/j.1600-0625.2011.01393.x.
3. Naik S, Bouladoux N, Wilhelm C, Molloy MJ, Salcedo R, Kastenmuller W, Deming C, Quinones M, Koo L, Conlan S, Spencer S, Hall JA, Dzutsev A, Kong H, Campbell DJ, Trinchieri G, Segre JA, Belkaid Y. 2012 Compartmentalized control of skin immunity by resident commensals. Science 337:1115-1119. http://dx.doi.org/10.1126/science.1225152.
4. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339:520-532 http://dx.doi.org/10.1056/NEJM199808203390806.
5. Nicolaides N. 1974. Skin lipids: their biochemical uniqueness. Science 186:19-26. http://dx.doi.org/10.1126/science.186.4158.19.
6. Ricketts CR, Squire JR, Topley E. 1951. Human skin lipids with particular reference to the self-sterilising power of the skin. Clin Sci 10:80-110.
7. Wille JJ, Kydonieus A. 2003. Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against gram-positive bacteria. Skin Pharmacol Appl Skin Physiol 16:176-187. http://dx.doi.org/10.1159/000069757.
8. Drake DR, Brogden KA, Dawson DV, Wertz PW. 2008. Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J Lipid Res 49:4-11.
9. Nakatsuji T, Kao MC, Fang JY, Zouboulis CC, Zhang L, Gallo RL, Huang CM. 2009. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol 129:2480-2488. http://dx.doi.org/10.1038/jid.2009.93.
10. Skrivanová E, Marounek M, Dlouha G, Kanka J. 2005. Susceptibility of Clostridium perfringens to C-C fatty acids. Lett Appl Microbiol 41:77-81. http://dx.doi.org/10.1111/j.1472-765X.2005.01709.x.
11. Kelsey JA, Bayles KW, Shafii B, McGuire MA. 2006. Fatty acids and monoacylglycerols inhibit growth of Staphylococcus aureus. Lipids 41: 951-961. http://dx.doi.org/10.1007/s11745-006-5048-z.
12. Holland KT, Ingham E, Cunliffe WJ. 1981. A review, the microbiology of acne. J Appl Bacteriol 51:195-215. http://dx.doi.org/10.1111/j.1365-2672.1981.tb01234.x.
13. Götz F, Verheij HM, Rosenstein R. 1998. Staphylococcal lipases: molecular characterisation, secretion, and processing. Chem Phys Lipids 93:15-25. http://dx.doi.org/10.1016/S0009-3084(98)00025-5.
14. Simons JW, Götz F, Egmond MR, Verheij HM. 1998. Biochemical properties of staphylococcal (phospho)lipases. Chem Phys Lipids 93:27-37. http://dx.doi.org/10.1016/S0009-3084(98)00026-7.
15. Simons JW, Adams H, Cox RC, Dekker N, Götz F, Slotboom AJ, Verheij HM. 1996. The lipase from Staphylococcus aureus. Expression in Escherichia coli, large-scale purification and comparison of substrate specificity to Staphylococcus hyicus lipase. Eur J Biochem 242:760-769.
16. Cadieux B, Vijayakumaran V, Bernards MA, McGavin MJ, Heinrichs DE. 2014. Role of lipase from community-associated methicillin-resistant Staphylococcus aureus strain USA300 in hydrolyzing triglycerides into growth-inhibitory free fatty acids. J Bacteriol 196:4044-4056. http://dx.doi.org/10.1128/JB.02044-14.
17. Fujie T, Shikiji T, Uchida N, Urano Y, Nagae H, Arase S. 1996. Culture of cells derived from the human sebaceous gland under serum-free conditions without a biological feeder layer or specific matrices. Arch Dermatol Res 288:703-708. http://dx.doi.org/10.1007/BF02505281.
18. Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE. 1999. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 113:1011-1020. http://dx.doi.org/10.1046/j.1523-1747.1999.00771.x.
19. Nakatsuji T, Kao MC, Zhang L, Zouboulis CC, Gallo RL, Huang CM. 2010 Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression. J Invest Dermatol 130:985-994. http://dx.doi.org/10.1038/jid.2009.384.
20. Lampe MA, Burlingame AL, Whitney J, Williams ML, Brown BE, Roitman E, Elias PM. 1983. Human stratum corneum lipids: characterization and regional variations. J Lipid Res 24:120-130.
21. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. 2009 Bacterial community variation in human body habitats across space and time. Science 326:1694-1697. http://dx.doi.org/10.1126/science.1177486.
22. Coates R, Moran J, Horsburgh MJ. 2014. Staphylococci: colonizers and pathogens of human skin. Future Microbiol 9:75-91. http://dx.doi.org/10.2217/fmb.13.145.
23. Galbraith H, Miller TB. 1973. Effect of long chain fatty acids on bacterial respiration and amino acid uptake. J Appl Bacteriol 36:659-675. http://dx.doi.org/10.1111/j.1365-2672.1973.tb04151.x.
24. Greenway DL, Dyke KG. 1979. Mechanism of the inhibitory action of linoleic acid on the growth of Staphylococcus aureus. J Gen Microbiol 115: 233-245. http://dx.doi.org/10.1099/00221287-115-1-233.
25. Cartron ML, England SR, Chiriac AI, Josten M, Turner R, Rauter Y, Hurd A, Sahl HG, Jones S, Foster SJ. 2014. Bactericidal activity of the human skin fatty acid cis-6-hexadecanoic acid on Staphylococcus aureus. Antimicrob Agents Chemother 58:3599-3609. http://dx.doi.org/10.1128/AAC.01043-13.
26. Neumann Y, Ohlsen K, Donat S, Engelmann S, Kusch H, Albrecht D, Cartron M, Hurd A, Foster SJ. 2015. The effect of skin fatty acids on Staphylococcus aureus. Arch Microbiol 197:245-267. http://dx.doi.org/10.1007/s00203-014-1048-1.
27. Clarke SR, Mohamed R, Bian L, Routh AF, Kokai-Kun JF, Mond JJ, Tarkowski A, Foster SJ. 2007. The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe 1:199-212. http://dx.doi.org/10.1016/j.chom.2007.04.005.
28. Köhler T, Weidenmaier C, Peschel A. 2009. Wall teichoic acid protects Staphylococcus aureus against antimicrobial fatty acids from human skin. J Bacteriol 191:4482-4484. http://dx.doi.org/10.1128/JB.00221-09.
29. Parsons JB, Frank MW, Jackson P, Subramanian C, Rock CO. 2014. Incorporation of extracellular fatty acids by a fatty acid kinase-dependent pathway in Staphylococcus aureus. Mol Microbiol 92:234-245. http://dx.doi.org/10.1111/mmi.12556.
30. Parsons JB, Yao J, Frank MW, Jackson P, Rock CO. 2012. Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus. J Bacteriol 194:5294-5304. http://dx.doi.org/10.1128/JB.00743-12.
31. Stoll H, Dengjel J, Nerz C, Götz F. 2005. Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect Immun 73:2411-2423. http://dx.doi.org/10.1128/IAI.73.4.2411-2423.2005.
32. Hashimoto M, Tawaratsumida K, Kariya H, Kiyohara A, Suda Y, Krikae F, Kirikae T, Götz F. 2006. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol 177:3162-3169. http://dx.doi.org/10.4049/jimmunol.177.5.3162.
33. Takeda K, Takeuchi O, Akira S. 2002. Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res 8:459-463. http://dx.doi.org/10.1177/09680519020080060101.
34. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 13:933-940. http://dx.doi.org/10.1093/intimm/13.7.933.
35. Schmaler M, Jann NJ, Ferracin F, Landolt LZ, Biswas L, Götz F, Landmann R. 2009. Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth in vivo. J Immunol 182: 7110-7118. http://dx.doi.org/10.4049/jimmunol.0804292.
36. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731-739. http://dx.doi.org/10.1016/S0140-6736(06)68231-7.
37. Geiger T, Francois P, Liebeke M, Fraunholz M, Goerke C, Krismer B, Schrenzel J, Lalk M, Wolz C. 2012. The stringent response of Staphylococcus aureus and its impact on survival after phagocytosis through the induction of intracellular PSMs expression. PLoS Pathog 8:e1003016. http://dx.doi.org/10.1371/journal.ppat.1003016.
38. Mauthe M, Yu W, Krut O, Kronke M, Götz F, Robenek H, Proikas-Cezanne T. 2012. WIPI-1 positive autophagosome-like vesicles entrap pathogenic Staphylococcus aureus for lysosomal degradation. Int J Cell Biol 2012:179207.
39. Nguyen MT, Kraft B, Yu W, Demicrioglu DD, Hertlein T, Burian M, Schmaler M, Boller K, Bekeredjian-Ding I, Ohlsen K, Schittek B, Götz F. 2015 The νSaα specific lipoprotein like cluster (lpl) of S. aureus USA300 contributes to immune stimulation and invasion in human cells. PLoS Pathog 11:e1004984. http://dx.doi.org/10.1371/journal.ppat.1004984.
40. Heinzelmann E, Berger S, Müller C, Hartner T, Poralla K, Wohlleben W, Schwartz D. 2005. An acyl-CoA dehydrogenase is involved in the formation of the Delta cis3 double bond in the acyl residue of the lipopeptide antibiotic friulimicin in Actinoplanes friuliensis. Microbiology 151: 1963-1974. http://dx.doi.org/10.1099/mic.0.27844-0.
41. Ziegler-Heitbrock HW, Schraut W, Wendelgass P, Strobel M, Sternsdorf T, Weber C, Aepfelbacher M, Ehlers M, Schutt C, Haas JG. 1994. Distinct patterns of differentiation induced in the monocytic cell line Mono Mac 6. J Leukoc Biol 55:73-80.
42. Kühner D, Stahl M, Demircioglu DD, Bertsche U. 2014. From cells to muropeptide structures in 24 h: peptidoglycan mapping by UPLC-MS. Sci Rep 4:7494. http://dx.doi.org/10.1038/srep07494.
43. Nega M, Dube L, Kull M, Ziebandt AK, Ebner P, Albrecht D, Krismer B, Rosenstein R, Hecker M, Götz F. 2015. Secretome analysis revealed adaptive and non-adaptive responses of the Staphylococcus carnosus femB mutant. Proteomics 15:1268-1279. http://dx.doi.org/10.1002/pmic.201400343.
44. Do TQ, Moshkani S, Castillo P, Anunta S, Pogosyan A, Cheung A, Marbois B, Faull KF, Ernst W, Chiang SM, Fujii G, Clarke CF, Foster K, Porter E. 2008. Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid. J Immunol 181:4177-4187. http://dx.doi.org/10.4049/jimmunol.181.6.4177.
45. Kenny JG, Ward D, Josefsson E, Jonsson IM, Hinds J, Rees HH, Lindsay JA, Tarkowski A, Horsburgh MJ. 2009. The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One 4:e4344. http://dx.doi.org/10.1371/journal.pone.0004344.
46. White DC, Frerman FE. 1968. Fatty acid composition of the complex lipids of Staphylococcus aureus during the formation of the membranebound electron transport system. J Bacteriol 95:2198-2209.
47. Arsic B, Zhu Y, Heinrichs DE, McGavin MJ. 2012. Induction of the staphylococcal proteolytic cascade by antimicrobial fatty acids in community acquired methicillin resistant Staphylococcus aureus. PLoS One 7:e45952. http://dx.doi.org/10.1371/journal.pone.0045952.
48. Parsons JB, Broussard TC, Bose JL, Rosch JW, Jackson P, Subramanian C, Rock CO. 2014. Identification of a two-component fatty acid kinase responsible for host fatty acid incorporation by Staphylococcus aureus. Proc Natl Acad Sci U S A 111:10532-10537. http://dx.doi.org/10.1073/pnas.1408797111.
49. Parsons JB, Frank MW, Subramanian C, Saenkham P, Rock CO. 2011. Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors. Proc Natl Acad Sci U S A 108: 15378-15383. http://dx.doi.org/10.1073/pnas.1109208108.
50. Pailler J, Aucher W, Pires M, Buddelmeijer N. 2012. Phosphatidylglycerol:: prolipoprotein diacylglyceryl transferase (Lgt) of Escherichia coli has seven transmembrane segments, and its essential residues are embedded in the membrane. J Bacteriol 194:2142-2151. http://dx.doi.org/10.1128/JB.06641-11.
51. Schmaler M, Jann NJ, Götz F, Landmann R. 2010. Staphylococcal lipoproteins and their role in bacterial survival in mice. Int J Med Microbiol 300:155-160. http://dx.doi.org/10.1016/j.ijmm.2009.08.018.
52. Kobayashi M, Yoshiki R, Sakabe J, Kabashima K, Nakamura M, Tokura Y. 2009. Expression of Toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes. Br J Dermatol 160:297-304. http://dx.doi.org/10.1111/j.1365-2133.2008.08897.x.
53. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. 2009. Skin immune sentinels in health and disease. Nat Rev Immunol 9:679-691.
54. Müller P, Müller-Anstett M, Wagener J, Gao Q, Kaesler S, Schaller M, Biedermann T, Götz F. 2010. The Staphylococcus aureus lipoprotein SitC colocalizes with Toll-like receptor 2 (TLR2) in murine keratinocytes and elicits intracellular TLR2 accumulation. Infect Immun 78:4243-4250. http://dx.doi.org/10.1128/IAI.00538-10.
55. Skabytska Y, Wolbing F, Gunther C, Koberle M, Kaesler S, Chen KM, Guenova E, Demircioglu D, Kempf WE, Volz T, Rammensee HG, Schaller M, Rocken M, Götz F, Biedermann T. 2014. Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. Immunity 41:762-775. http://dx.doi.org/10.1016/j.immuni.2014.10.009.
56. Spohn R, Buwitt-Beckmann U, Brock R, Jung G, Ulmer AJ, Wiesmüller KH. 2004. Synthetic lipopeptide adjuvants and Toll-like receptor 2-structure-activity relationships. Vaccine 22:2494-2499. http://dx.doi.org/10.1016/j.vaccine.2003.11.074.
57. Schild H, Deres K, Wiesmüller KH, Jung G, Rammensee HG. 1991. Efficiency of peptides and lipopeptides for in vivo priming of virusspecific cytotoxic T cells. Eur J Immunol 21:2649-2654. http://dx.doi.org/10.1002/eji.1830211102.
58. Deres K, Schild H, Wiesmüller KH, Jung G, Rammensee HG. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342:561-564. http://dx.doi.org/10.1038/342561a0.
59. Zaman M, Toth I. 2013. Immunostimulation by synthetic lipopeptidebased vaccine candidates: structure-activity relationships. Front Immunol 4:318.
60. Zaman M, Abdel-Aal AB, Fujita Y, Phillipps KS, Batzloff MR, Good MF, Toth I. 2012. Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship. PLoS One 7:e30146. http://dx.doi.org/10.1371/journal.pone.0030146.
61. Farhat K, Riekenberg S, Heine H, Debarry J, Lang R, Mages J, Buwitt-Beckmann U, Roschmann K, Jung G, Wiesmüller KH, Ulmer AJ. 2008. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J Leukoc Biol 83:692-701.
62. Kloos WE, Musselwhite MS. 1975. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol 30:381-385.